Home/Filings/4/0001209191-21-030925
4//SEC Filing

North Annette 4

Accession 0001209191-21-030925

CIK 0001595893other

Filed

May 6, 8:00 PM ET

Accepted

May 7, 4:37 PM ET

Size

7.2 KB

Accession

0001209191-21-030925

Insider Transaction Report

Form 4
Period: 2021-05-06
North Annette
EVP, General Counsel & Secty.
Transactions
  • Exercise/Conversion

    Common Stock

    2021-05-06$17.00/sh+5,882$99,99412,365 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-05-065,882169,609 total
    Exercise: $17.00Exp: 2029-04-14Common Stock (5,882 underlying)
Footnotes (1)
  • [F1]One-fourth of the option vested on April 15, 2020. Thereafter, 1/48th of the Option vests on a monthly basis over 36 months until the option becomes fully vested.

Issuer

Turning Point Therapeutics, Inc.

CIK 0001595893

Entity typeother

Related Parties

1
  • filerCIK 0001341011

Filing Metadata

Form type
4
Filed
May 6, 8:00 PM ET
Accepted
May 7, 4:37 PM ET
Size
7.2 KB